Pharmacokinetics of chemotherapy in the older patient Review uri icon

Overview

MeSH Major

  • Aging
  • Antineoplastic Agents
  • Neoplasms

abstract

  • Additional studies are needed to address the pharmacokinetics and pharmacodynamics of cancer therapies in the older patient. Multicenter pharmacokinetic studies of adequate sample size, which include a thorough evaluation of physiologic factors and geriatric assessment parameters, would provide further insight into the factors affecting treatment tolerance. These studies would also help to guide appropriate chemotherapy dosing and interventions in order to maximize efficacy and minimize toxicity in the older patient.

publication date

  • January 2007

Research

keywords

  • Review

Identity

Language

  • eng

PubMed ID

  • 17242669

Additional Document Info

start page

  • 32

end page

  • 43

volume

  • 14

number

  • 1